|
Sun Pharma, Zydus to co-market drug for CKD-induced anaemia
![IndiaTimes]()
Monday, 30 October 2023
Leading Indian drugmakers, Zydus Lifesciences and Sun Pharmaceutical industries entered into a licensing agreement to co-market Desidustat, an oral treatment for anaemia, associated with chronic kidney disease (CKD). The agreement allows Sun Pharma to co-market the product developed by Zydus Lifesciences Limited, the companies announced in a joint note. Desidustat is an oral treatment for anemia associated with chronic kidney disease (CKD) in India.
|
|
Monday, 30 October 2023
